Industry News
Pharmaceutical Industry News
After a nasty quarter for AbbVie’s migraine franchise, Biohaven investors worry about pricing
After a nasty quarter for AbbVie's migraine franchise, Biohaven investors worry about pricing aliu Mon, 05/02/2022 - 06:38
Fuad El-Hibri, Who Led a Troubled Vaccine Maker, Dies at 64
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
Klick Health brings on creative veteran Romero, formerly of The Bloc, for unique ‘Maker’ role
Klick Health brings on creative veteran Romero, formerly of The Bloc, for unique 'Maker' role nmissakian Fri, 04/29/2022 - 20:58
AbbVie’s red-hot Rinvoq scores fourth FDA approval in five months
AbbVie's red-hot Rinvoq scores fourth FDA approval in five months kdunleavy Fri, 04/29/2022 - 16:40
AbbVie’s red-hot Rinvoq scores 4th FDA approval in 5 months
AbbVie's red-hot Rinvoq scores 4th FDA approval in 5 months kdunleavy Fri, 04/29/2022 - 16:40
Pfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor
Pfizer loses top vaccine scientist Jansen who led drive for COVID-19 shot, searches for successor esagonowsky Fri, 04/29/2022 - 15:23
Novo’s Wegovy supply rebound on track for later this year as demand stays strong
Novo's Wegovy supply rebound on track for later this year as demand stays strong fkansteiner Fri, 04/29/2022 - 13:32
Amid legal tumult, J&J shareholders reject proposal to end talc sales worldwide
Amid legal tumult, J&J shareholders reject proposal to end talc sales worldwide kdunleavy Fri, 04/29/2022 - 13:04
Amid Humira’s decline, AbbVie’s Rinvoq falls short of analyst forecasts and Skyrizi delivers
Amid Humira's decline, AbbVie's Rinvoq falls short of analyst forecasts and Skyrizi delivers zbecker Fri, 04/29/2022 - 11:05
AstraZeneca’s Farxiga hits $1B quarterly mark, but flagship oncology and China units lag
AstraZeneca’s Farxiga hits $1B quarterly mark, but flagship oncology and China units lag aliu Fri, 04/29/2022 - 10:46
Innovating One of the World’s Most Common Vaccines in Era of Consumer Choice
Innovating One of the World’s Most Common Vaccines in Era of Consumer Choice mwen Fri, 04/29/2022 - 10:37
As superstar Revlimid fades faster than expected, BMS trims $600M from its 2022 sales projection
As superstar Revlimid fades faster than expected, BMS trims $600M from its 2022 sales projection kdunleavy Fri, 04/29/2022 - 10:02
Fierce Pharma Asia—Astellas’ gene therapy ding; BeiGene, Novartis’ PD-1 win; Serum Institute’s unused COVID shots
Fierce Pharma Asia—Astellas’ gene therapy ding; BeiGene, Novartis’ PD-1 win; Serum Institute’s unused COVID shots aliu Fri, 04/29/2022 - 08:53
Biogen CEO’s 2021 pay remains level despite Aduhelm tribulations
Biogen CEO's 2021 pay remains level despite Aduhelm tribulations fkansteiner Fri, 04/29/2022 - 08:21
Gilead’s two cents: Drugmaker gets a boost from Biktarvy, Veklury but $2.7B writedown crushes earnings
Gilead's two cents: Drugmaker gets a boost from Biktarvy, Veklury but $2.7B writedown crushes earnings zbecker Fri, 04/29/2022 - 08:03
How to reach Hispanics with healthcare messages? Mine the data first, Klick says
How to reach Hispanics with healthcare messages? Mine the data first, Klick says sharon.coey Fri, 04/29/2022 - 03:37
Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims
The data have not yet been peer reviewed or published. But experts said the drug may give people with obesity an alternative to bariatric surgery.
The Top Line podcast: Pharma advertising shifts gears and Novartis taps a surprising M&A czar, plus this week’s headlines
The Top Line podcast: Pharma advertising shifts gears and Novartis taps a surprising M&A czar, plus this week's headlines tcarey Thu, 04/28/2022 - 20:30
CMI Media Group launches new practice to help pharma reach out to diverse audiences
CMI Media Group launches new practice to help pharma reach out to diverse audiences nmissakian Thu, 04/28/2022 - 18:15
How to Get Covid Treatments in New York City
Both antiviral pills and monoclonal antibodies that treat Covid-19 are available across the city, but some public health experts worry that too few people know how to get them.